BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 20695799)

  • 1. Multicenter study of Clostridium difficile infection rates from 2000 to 2006.
    Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.
    Dubberke ER; Butler AM; Hota B; Khan YM; Mangino JE; Mayer J; Popovich KJ; Stevenson KB; Yokoe DS; McDonald LC; Jernigan J; Fraser VJ;
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):518-25. PubMed ID: 19419269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
    Lambert PJ; Dyck M; Thompson LH; Hammond GW
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?
    Dubberke ER; McMullen KM; Mayfield JL; Reske KA; Georgantopoulos P; Warren DK; Fraser VJ
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):332-7. PubMed ID: 19239377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of administrative data for evaluating the shifting acquisition of Clostridium difficile infection in England.
    Jen MH; Saxena S; Bottle A; Pollok R; Holmes A; Aylin P
    J Hosp Infect; 2012 Mar; 80(3):229-37. PubMed ID: 22306443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Community and Healthcare-onset Clostridium difficile Infections.
    Mora Pinzon MC; Buie R; Liou JI; Shirley DK; Evans CT; Ramanathan S; Poggensee L; Safdar N
    Clin Infect Dis; 2019 Apr; 68(8):1343-1350. PubMed ID: 30668844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden.
    Murphy CR; Avery TR; Dubberke ER; Huang SS
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):20-8. PubMed ID: 22173518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network.
    Turner NA; Grambow SC; Woods CW; Fowler VG; Moehring RW; Anderson DJ; Lewis SS
    JAMA Netw Open; 2019 Oct; 2(10):e1914149. PubMed ID: 31664443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.
    Kuntz JL; Chrischilles EA; Pendergast JF; Herwaldt LA; Polgreen PM
    BMC Infect Dis; 2011 Jul; 11():194. PubMed ID: 21762504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes.
    Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Stevenson KB; McDonald LC; Olsen MA; Fraser VJ;
    Infect Control Hosp Epidemiol; 2010 Mar; 31(3):262-8. PubMed ID: 20100085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.
    Kutty PK; Benoit SR; Woods CW; Sena AC; Naggie S; Frederick J; Engemann J; Evans S; Pien BC; Banerjee SN; Engel J; McDonald LC
    Infect Control Hosp Epidemiol; 2008 Mar; 29(3):197-202. PubMed ID: 18241032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridioides difficile incidence related to in-hospital cephalosporin use: a tale of two highly comparable hospitals.
    Karp J; Edman-Wallér J; Toepfer M; Lundqvist A; Jacobsson G
    J Antimicrob Chemother; 2019 Jan; 74(1):182-189. PubMed ID: 30358837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA.
    Naggie S; Frederick J; Pien BC; Miller BA; Provenzale DT; Goldberg KC; Woods CW
    Infection; 2010 Aug; 38(4):297-300. PubMed ID: 20454827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006.
    Campbell RJ; Giljahn L; Machesky K; Cibulskas-White K; Lane LM; Porter K; Paulson JO; Smith FW; McDonald LC
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):526-33. PubMed ID: 19419272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated surveillance of Clostridium difficile infections using BioSense.
    Benoit SR; McDonald LC; English R; Tokars JI
    Infect Control Hosp Epidemiol; 2011 Jan; 32(1):26-33. PubMed ID: 21128815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
    Longtin Y; Paquet-Bolduc B; Gilca R; Garenc C; Fortin E; Longtin J; Trottier S; Gervais P; Roussy JF; Lévesque S; Ben-David D; Cloutier I; Loo VG
    JAMA Intern Med; 2016 Jun; 176(6):796-804. PubMed ID: 27111806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial-acquired and community-onset Clostridium difficile infection at an academic hospital in Italy: Epidemiology, recurrences and toxin genes distribution.
    Visconti V; Brunetti G; Cuomo MR; Giordano A; Raponi G
    J Infect Chemother; 2017 Nov; 23(11):763-768. PubMed ID: 28899610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.